Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2020-01-09 16:03:30
Reporting Period:
Accepted Time:
2020-01-09 16:03:30
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1103021 Biodelivery Sciences International Inc BDSI Pharmaceutical Preparations (2834) 352089858
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1301715 A Mark Sirgo C/o Biodelivery Sciences Intl, Inc.,
4131 Parklake Avenue, Suite 225
Raleigh NC 27612
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-01-07 13,353 $5.65 1,478,124 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
  1. The shares of Common Stock were automatically sold under a pre-planned 10b5-1 trading plan.
  2. On January 7, 2020, the Reporting Person sold an aggregate of 13,353 shares of the Issuer's Common Stock at a weighted average price of $5.65 per share. The highest sale price for the Common Stock was $5.80 per share and the lowest sale price was $5.56 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes.